e-learning
resources
Berlin 2001
Tuesday 25.09.2001
Pulmonary thromboembolism and infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The genetic polymorphisms associated with acute pulmonary embolism (PE) and deep venous thrombosis (DVT)
L. Adamek, P. Grzanka, M. Sanak, M. Krzanowski, E. Nizankowska, A. Szczeklik (Cracow, Poland)
Source:
Annual Congress 2001 - Pulmonary thromboembolism and infections
Session:
Pulmonary thromboembolism and infections
Session type:
Thematic Poster Session
Number:
2613
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Adamek, P. Grzanka, M. Sanak, M. Krzanowski, E. Nizankowska, A. Szczeklik (Cracow, Poland). The genetic polymorphisms associated with acute pulmonary embolism (PE) and deep venous thrombosis (DVT). Eur Respir J 2001; 16: Suppl. 31, 2613
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Clinical presentation and outcome of venous thromboembolism in COPD
Source: Eur Respir J 2012; 39: 862-868
Year: 2012
Association between risk stratification for pulmonary embolism and deep vein thrombosis of lower extremities
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
Risk of deep vein thrombosis and pulmonary embolism in asthma
Source: Eur Respir J 2013; 42: 655-661
Year: 2013
Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005
Clinical significance of deep venous thrombosis in symptomatic pulmonary embolism
Source: International Congress 2017 – Pulmonary embolism
Year: 2017
Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)?
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development
Source: Eur Respir J 2003; 22: Suppl. 45, 221s
Year: 2003
Modern treatment of pulmonary embolism
Source: Eur Respir J 2002; 19: 22S-27S
Year: 2002
Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
The COPD frequency in patients with venous thrombosis
Source: Eur Respir J 2005; 26: Suppl. 49, 57s
Year: 2005
Prognostic significance of asymptomatic pulmonary embolism in patients with deep vein thrombosis
Source: Eur Respir J 2004; 24: Suppl. 48, 685s
Year: 2004
Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Chronic thromboembolic pulmonary hypertension: update 2004
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=243
Year: 2004
Deep venous thrombosis associated with pulmonary tuberculosis
Source: Annual Congress 2007 - Difficult tuberculosis cases I
Year: 2007
Anomalous pulmonary venous drainage (APVD) in patients with suspected pulmonary hypertension (PH)
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Venous thromboemboli and exacerbations of COPD
Source: Eur Respir J 2010; 35: 1243-1248
Year: 2010
Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case?control study from Sweden
Source: Eur Respir J , 49 (2) 1601014; DOI: 10.1183/13993003.01014-2016
Year: 2017
Risk factors and clinical significance of residual perfusion defects after symptomatic pulmonary embolism (PE)
Source: Annual Congress 2007 - Acute and chronic pulmonary embolism
Year: 2007
Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept